CA2678795A1 — Antibacterial cyclohexylsulfanyl pleuromutilins
Assigned to Nabriva Therapeutics AG · Expires 2008-09-25 · 18y expired
What this patent protects
A compound of formula (I) (see formula I) wherein the residues have various meanings, optionally in the form of a salt and/or solvate, its use for the preparation of a medicament for the treatment of diseases mediated by bacteria and a pharmaceutical composition comprising such c…
USPTO Abstract
A compound of formula (I) (see formula I) wherein the residues have various meanings, optionally in the form of a salt and/or solvate, its use for the preparation of a medicament for the treatment of diseases mediated by bacteria and a pharmaceutical composition comprising such compound.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.